Treatment of patients with fibromyalgia syndrome using the Rességuier and Qi Gong methods

Completed

• Conditions: Fibromyalgia syndrome; Musculoskeletal Diseases; Fibromyalgia

• Registration Number: ISRCTN99342127
• Lead Sponsor: niversity of Florence (Italy)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-17
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Diagnosis of fibromyalgia syndrome according to the American College of Rheumatology (ACR) criteria

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The following items are assessed at baseline (T0), at end of the first (week 7: T1) and the second treatment (week 15: T2) and after 9 weeks of follow-up (week 27: FU):<br>1. Pain assessed by regional pain scale (RPS)<br>2. Disability assessed by Fibromyalgia Impact Questionnarie (FIQ) and Health Assessment Questionnaire (HAQ)

Secondary Outcome Measures

Name	Time	Method
The following items are assessed at baseline (T0), at end of the first (week 7: T1) and the second treatment (week 15: T2) and after 9 weeks of follow-up (week 27: FU):<br>1. Tenderness in specific FMS sites (by the tender points evaluation)<br>2. Quality of life by Medical Outcomes Survey Short Form 36 (SF-36)<br>3. Anxiety and Depression by Hospital Anxiety and Depression Scale (HADS), with subscales for anxiety (HADS-a) and depression (HADS-d)<br>4. Quality of sleep by a number rating scale 0?10 (NRS- 0?10)